» Articles » PMID: 20441782

The EPR Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect

Overview
Specialty Pharmacology
Date 2010 May 6
PMID 20441782
Citations 949
Authors
Affiliations
Soon will be listed here.
Abstract

The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid tumors related to their anatomical and pathophysiological differences from normal tissues. For example, angiogenesis leads to high vascular density in solid tumors, large gaps exist between endothelial cells in tumor blood vessels, and tumor tissues show selective extravasation and retention of macromolecular drugs. This EPR effect served as a basis for development of macromolecular anticancer therapy. We demonstrated methods to enhance this effect artificially in clinical settings. Of great importance was increasing systolic blood pressure via slow angiotensin II infusion. Another strategy involved utilization of NO-releasing agents such as topical nitroglycerin, which releases nitrite. Nitrite is converted to NO more selectively in the tumor tissues, which leads to a significantly increased EPR effect and enhanced antitumor drug effects as well. This review discusses molecular mechanisms of factors related to the EPR effect, the unique anatomy of tumor vessels, limitations and techniques to avoid such limitations, augmenting tumor drug delivery, and experimental and clinical findings.

Citing Articles

Global trends and research hotspots in nanodrug delivery systems for breast cancer therapy: a bibliometric analysis (2013-2023).

Li Y, Liu P, Zhang B, Chen J, Yan Y Discov Oncol. 2025; 16(1):269.

PMID: 40047951 PMC: 11885776. DOI: 10.1007/s12672-025-02014-3.


Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.

Yang H, Li J, Song C, Li H, Luo Q, Chen M Int J Mol Sci. 2025; 26(4).

PMID: 40004206 PMC: 11855571. DOI: 10.3390/ijms26041743.


Future Perspectives on the Automation and Biocompatibility of Molecularly Imprinted Polymers for Healthcare Applications.

Garg S, Singla P, Kaur S, Canfarotta F, Velliou E, Dawson J Macromolecules. 2025; 58(3):1157-1168.

PMID: 39958488 PMC: 11823616. DOI: 10.1021/acs.macromol.4c01621.


Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.

Izadiyan Z, Misran M, Kalantari K, Webster T, Kia P, Basrowi N Int J Nanomedicine. 2025; 20:1213-1262.

PMID: 39911259 PMC: 11794392. DOI: 10.2147/IJN.S488961.


Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):31.

PMID: 39891269 PMC: 11783920. DOI: 10.1186/s12944-024-02429-x.